Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis-Reference-Cited by-同舟云学术

Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis

Published:2011-06-17 Issue:13 Volume:18 Page:3657-3665
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Mayo Skye C.,de Jong Mechteld C.,Bloomston Mark,Pulitano Carlo,Clary Bryan M.,Reddy Srinevas K.,Clark Gamblin T.,Celinski Scott A.,Kooby David A.,Staley Charles A.,Stokes Jayme B.,Chu Carrie K.,Arrese David,Ferrero Alessandro,Schulick Richard D.,Choti Michael A.,Geschwind Jean-Francois H.,Strub Jennifer,Bauer Todd W.,Adams Reid B.,Aldrighetti Luca,Mentha Gilles,Capussotti Lorenzo,Pawlik Timothy M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-011-1832-y.pdf

Reference32 articles.

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–59.

2. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 2000;190:432–45.

3. Chen H, Hardacre JM, Uzar A, et al. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg. 1998;187:88–92.

4. Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10:1171–5.

5. Nave H, Mossinger E, Feist H, et al. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery. 2001;129:170–5.

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic Disease;Journal of Clinical Medicine;2024-08-23

2. Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysis;HPB;2024-08

3. Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy;Annals of Surgical Oncology;2024-05-08

4. Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum;Annals of Surgical Oncology;2024-04-30

5. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review;Chinese Clinical Oncology;2024-04